Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Thallion Pharmaceuticals Inc V.TLN



TSXV:TLN - Post by User

Post by Everswanon Jun 03, 2009 6:46pm
122 Views
Post# 16041625

ASCO 2009 final tally

ASCO 2009 final tally
https://blog.pharmexec.com/2009/06/03/latest-news-from-asco/


Last night I posted about Recentin and Zactima.
Two reasons why Astra will persue a takeover with TLN.

Zactima is a TKI inhibitor but with a broader based then Iressa
Recentin is also a TKI which if combine with 4601 could be as good or better than XL-184 but with very few side effect.

Combo Zactima + Chemo + 4601 looks fantastic. Same for Recentin Chemo and 4601.


I am not a believer of Vaccine therapy for cancer... we will see...
Bullboard Posts